Vivotif Market 2026 benefiting from increasing typhoid vaccination awareness

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Vivotif Market At The End Of The 2026–2030 Forecast Period?

The historical growth can be attributed to the rising occurrence of typhoid in endemic regions, the expansion of global travel into areas of elevated risk, governmental immunization programs, the widespread availability of oral vaccine types, and an increase in general public health awareness.

The projected expansion during this period stems from heightened investments in proactive health measures, a surge in demand for travel-related vaccinations, the broader reach of pediatric immunization programs, increased attention to preventing antimicrobial resistance, and better availability of vaccines in developing markets.

Significant inclinations anticipated throughout the forecast period encompass the wider implementation of oral immunization initiatives, a growing need for vaccines associated with travel, increased attention to the proactive management of infectious diseases, broader deployment of cold-chain optimized vaccine delivery systems, and a better understanding of typhoid prevention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20449&type=smp

What Drivers Are Shaping The Future Growth Of The Vivotif Market?

A rising occurrence of typhoid fever is anticipated to boost the vivotif market’s expansion in the future. Typhoid fever, a bacterial illness stemming from Salmonella Typhi, is transmitted via tainted food or water, leading to symptoms such as fever, stomach discomfort, and tiredness. This rise in typhoid fever cases is linked to inadequate sanitation, insufficient access to potable water, and increasing antibiotic resistance, particularly prevalent in lower-income areas. Vivotif contributes to lowering typhoid fever rates by offering a preventative oral vaccine targeting Salmonella Typhi, especially beneficial in areas with substandard hygiene. For example, in August 2024, data released by GOV.UK, a government platform from the UK, showed that in 2023, approximately 645 cases of typhoid fever were reported across England, Wales, and Northern Ireland. This represented an increase from 470 cases in 2022, highlighting a year-on-year rise in the disease’s occurrence. Consequently, the heightened incidence of typhoid fever is propelling the expansion of the vivotif market.

What Segment Types Make Up The Vivotif Market?

The vivotif market covered in this report is segmented –

1) By Clinical Indication: Typhoid, Other Indications

2) By Distribution Channel: Direct Sales, Online Pharmacies, Retail Pharmacies

3) By End-User: Adults, Pediatric

Who Are The Key Players Driving Competition In The Vivotif Market?

Major companies operating in the vivotif market are Bavarian Nordic A/S

Read the full vivotif market report here:

https://www.thebusinessresearchcompany.com/report/vivotif-global-market-report

Which Geographic Regions Are Influencing Demand In The Vivotif Market?

Asia-Pacific was the largest region in the vivotif market in 2025. The regions covered in the vivotif market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vivotif Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20449&type=smp

Browse Through More Reports Similar to the Global Vivotif Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Biosimilar Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

Biologics Contract Development Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795